| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.19 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |